Tokyo - Delayed Quote JPY

Japan Tissue Engineering Co., Ltd. (7774.T)

594.00
+13.00
+(2.24%)
As of 11:30:00 AM GMT+9. Market Open.
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
2,514,189
2,514,189
2,032,448
2,103,443
2,257,609
Cost of Revenue
823,555
823,555
895,848
847,960
1,100,637
Gross Profit
1,690,634
1,690,634
1,136,599
1,255,483
1,156,972
Operating Expense
1,546,122
1,546,122
1,864,714
1,753,660
1,623,828
Operating Income
144,512
144,512
-728,115
-498,177
-466,856
Net Non Operating Interest Income Expense
782
782
1,144
2,401
3,039
Pretax Income
147,009
147,009
-725,477
-494,049
-462,782
Tax Provision
3,840
3,840
3,840
3,840
3,840
Net Income Common Stockholders
143,169
143,169
-729,317
-497,889
-466,622
Diluted NI Available to Com Stockholders
143,169
143,169
-729,317
-497,889
-466,622
Basic EPS
3.53
3.53
-17.96
-12.26
-11.49
Diluted EPS
3.53
3.53
-17.96
-12.26
-11.49
Basic Average Shares
40,609.96
40,609.96
40,609.96
40,609.96
40,609.98
Diluted Average Shares
40,609.96
40,609.96
40,609.96
40,609.96
40,609.98
Total Operating Income as Reported
144,506
144,506
-728,119
-498,182
-466,861
Rent Expense Supplemental
15,113
15,113
15,370
17,579
25,732
Total Expenses
2,369,677
2,369,677
2,760,562
2,601,620
2,724,465
Net Income from Continuing & Discontinued Operation
143,169
143,169
-729,317
-497,889
-466,622
Normalized Income
143,169
143,169
-729,317
-496,808.42
-466,604.66
Interest Income
782
782
1,144
2,401
3,039
Net Interest Income
782
782
1,144
2,401
3,039
EBIT
144,512
144,512
-728,115
-498,177
-466,856
EBITDA
278,560
278,560
-596,662
-373,204
-338,623
Reconciled Cost of Revenue
823,555
823,555
895,848
847,960
1,100,637
Reconciled Depreciation
134,048
134,048
131,453
124,973
128,233
Net Income from Continuing Operation Net Minority Interest
143,169
143,169
-729,317
-497,889
-466,622
Total Unusual Items Excluding Goodwill
0
0
0
-1,407
-25
Total Unusual Items
0
0
0
-1,407
-25
Normalized EBITDA
278,560
278,560
-596,662
-371,797
-338,598
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-326.42
-7.66
3/31/2021 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

000504.SZ Landfar Bio-medicine Co., Ltd
7.00
+1.01%
 
203400.KQ ABION Inc.
5,220.00
-1.69%
 
344860.KQ INNOGENE Co.,Ltd.
2,000.00
+0.60%
 
130A.T VERITAS IN SILICO INC
684.00
-0.44%
 
302440.KS SK bioscience Co.,Ltd.
42,950.00
+0.23%
 
475960.KQ TOMOCUBE
26,200.00
-0.19%
 
CONCORDBIO.BO Concord Biotech Limited
1,637.40
+6.88%
 
086900.KQ Medy-Tox Inc.
168,100.00
-0.06%
 
4565.T Nxera Pharma Co., Ltd.
871.00
+8.06%
 
347850.KQ D&D Pharmatech
85,600.00
+0.12%